Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam.

Oliveira MS, Costa SF, Pedri Ed, van der Heijden I, Levin AS.

Clinics (Sao Paulo). 2013 Apr;68(4):569-73. doi: 10.6061/clinics/2013(04)21.

PMID:
23778333
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

Oliveira MS, Prado GV, Costa SF, Grinbaum RS, Levin AS.

J Antimicrob Chemother. 2008 Jun;61(6):1369-75. doi: 10.1093/jac/dkn128. Epub 2008 Mar 25.

PMID:
18367459
[PubMed - indexed for MEDLINE]
Free Article
3.

In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii.

Pandey A, Kapil A, Sood S, Goel V, Das B, Seth P.

J Clin Microbiol. 1998 Nov;36(11):3415-6.

PMID:
9774610
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.

Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V.

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S95-100.

PMID:
22043760
[PubMed - indexed for MEDLINE]
5.

Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.

Hiraki Y, Yoshida M, Masuda Y, Inoue D, Tsuji Y, Kamimura H, Karube Y, Takaki K, Kawano F.

Int J Infect Dis. 2013 Dec;17(12):e1234-6. doi: 10.1016/j.ijid.2013.05.002. Epub 2013 Jun 21.

PMID:
23791858
[PubMed - indexed for MEDLINE]
Free Article
6.

Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.

Sheng WH, Wang JT, Li SY, Lin YC, Cheng A, Chen YC, Chang SC.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):380-6. doi: 10.1016/j.diagmicrobio.2011.03.003. Epub 2011 May 10.

PMID:
21558048
[PubMed - indexed for MEDLINE]
7.

Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam.

Jiménez-Mejías ME, Pachón J, Becerril B, Palomino-Nicás J, Rodríguez-Cobacho A, Revuelta M.

Clin Infect Dis. 1997 May;24(5):932-5.

PMID:
9142795
[PubMed - indexed for MEDLINE]
Free Article
8.

[Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].

Zhang TQ, Dong L, Wang ZY, Li HY.

Zhonghua Er Ke Za Zhi. 2011 Jul;49(7):545-9. Chinese.

PMID:
22088187
[PubMed - indexed for MEDLINE]
9.

Use of inhaled ampicillin-sulbactam against multiresistant Acinetobacter baumannii in bronchial secretions of intensive care unit patients.

Horianopoulou M, Kanellopoulou M, Paraskevopoulos I, Kyriakidis A, Legakis NJ, Lambropoulos S.

Clin Microbiol Infect. 2004 Jan;10(1):85-6. No abstract available.

PMID:
14706094
[PubMed - indexed for MEDLINE]
10.

High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii.

Betrosian AP, Frantzeskaki F, Xanthaki A, Georgiadis G.

Scand J Infect Dis. 2007;39(1):38-43.

PMID:
17366011
[PubMed - indexed for MEDLINE]
11.

Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.

Kuo LC, Lai CC, Liao CH, Hsu CK, Chang YL, Chang CY, Hsueh PR.

Clin Microbiol Infect. 2007 Feb;13(2):196-8.

PMID:
17328733
[PubMed - indexed for MEDLINE]
12.

[Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].

Sayin Kutlu S, Saçar S, Süzer T, Cevahir N, Okke D, Dirgen Caylak S, Turgut H.

Mikrobiyol Bul. 2008 Apr;42(2):353-8. Turkish.

PMID:
18697435
[PubMed - indexed for MEDLINE]
13.

In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.

Tong W, Wang R, Chai D, Li Z, Pei F.

Int J Antimicrob Agents. 2006 Nov;28(5):454-6. Epub 2006 Sep 20.

PMID:
16987639
[PubMed - indexed for MEDLINE]
14.

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii.

Corbella X, Ariza J, Ardanuy C, Vuelta M, Tubau F, Sora M, Pujol M, Gudiol F.

J Antimicrob Chemother. 1998 Dec;42(6):793-802.

PMID:
10052904
[PubMed - indexed for MEDLINE]
Free Article
15.

In vitro activity of sulbactam plus ampicillin against hospital isolates of coagulase-negative staphylococci and Acinetobacter species.

Frank U, Daschner FD.

Infection. 1989 Jul-Aug;17(4):272-4.

PMID:
2767773
[PubMed - indexed for MEDLINE]
16.

Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem.

Levin AS.

Clin Microbiol Infect. 2002 Mar;8(3):144-53. Review.

PMID:
12010169
[PubMed - indexed for MEDLINE]
17.
18.

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.

Levin AS, Levy CE, Manrique AE, Medeiros EA, Costa SF.

Int J Antimicrob Agents. 2003 Jan;21(1):58-62.

PMID:
12507838
[PubMed - indexed for MEDLINE]
19.

Treatment of pan-drug resistant Acinetobacter baumannii.

Lee CM, Lim HK, Liu CP, Tseng HK.

Scand J Infect Dis. 2005;37(3):195-9.

PMID:
15849052
[PubMed - indexed for MEDLINE]
20.

[In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii].

López-Hernández S, Alarcón T, Delgado T, de Las Cuevas MC, López-Brea M.

Rev Esp Quimioter. 1999 Jun;12(2):140-3. Spanish.

PMID:
10562675
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk